报价延迟最少15分钟:2026/03/12 05:29 EDT
盘前时段
|
||||
|
27.22 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
27.8
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.72/-0.98
|
|
企业价值
1.44B
|
| 资产负债 |
|
每股账面净值
6.49
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
308.05M
|
|
每股收益
2.06
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S. |
